Aquatic Capital Management LLC

Position in ZTS — Zoetis Inc.

CIK 1803916 CHICAGO, IL

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,895,851

-$6,713,910 QoQ

Shares Held

16,038

-72.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $20,937,777 across 21 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (9.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	140,331	$5,296,091
2	TEVA	Teva Pharmaceutical Industries Ltd	97,897	$2,948,657
3	TAK	Takeda Pharmaceutical Co Ltd	153,759	$2,847,616
4	RDY	Dr Reddys Laboratories Ltd	198,046	$2,742,937
5	ZTS	Zoetis Inc. This page	16,038	$1,895,851
6	VTRS	Viatris Inc	99,833	$1,348,743
7	NBIX	Neurocrine Biosciences Inc	6,375	$839,842
8	AQST	Aquestive Therapeutics, Inc.	141,350	$586,602

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,895,851	16,038	-72.7%	Shares	Sole	2026-05-15
2025-09-30	$8,609,761	58,842	-44.5%	Shares	Sole	2025-11-14
2025-06-30	$16,524,929	105,963	+6723.1%	Shares	Sole	2025-08-14
2025-03-31	$255,701	1,553	-90.1%	Shares	Sole	2025-05-15
2024-12-31	$2,552,950	15,669	-37.8%	Shares	Sole	2025-02-14
2024-06-30	$4,368,672	25,200	-88.9%	Shares	Sole	2024-08-14
2024-03-31	$38,546,038	227,800	+564.1%	Shares	Sole	2024-05-15
2023-06-30	$5,906,803	34,300	+411.9%	Shares	Sole	2023-08-14
2022-12-31	$981,885	6,700	+168.0%	Shares	Sole	2023-02-14
2022-09-30	$370,725	2,500	+525.0%	Shares	Sole	2022-11-14
2022-03-31	$75,436	400	0.0%	Shares	Sole	2022-05-16
2021-12-31	$97,612	400	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.